EXANE DERIVATIVES - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 115 filers reported holding ADMA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q1 2022$2,377,000
-94.1%
1,299
-95.4%
0.00%
-90.0%
Q4 2021$39,969,000
+1251.2%
28,348
+1768.7%
0.01%
+900.0%
Q4 2020$2,958,000
-18.4%
1,5170.0%0.00%0.0%
Q3 2020$3,625,000
-95.7%
1,517
-94.7%
0.00%
-95.5%
Q2 2020$83,655,00028,5530.02%
Other shareholders
ADMA BIOLOGICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$13,240,00011.29%
Stonepine Capital Management, LLC 7,661,690$25,360,1948.50%
Altium Capital Management LP 2,870,000$9,499,7005.27%
Caligan Partners LP 1,662,613$5,503,2493.84%
AWM Investment Company, Inc. 6,015,000$19,909,6502.69%
Perceptive Advisors 11,900,255$39,389,8441.16%
EAM Investors, LLC 1,035,752$3,428,3390.67%
OBERWEIS ASSET MANAGEMENT INC/ 1,169,500$3,871,0450.60%
Magnetar Financial LLC 7,074,722$23,417,3300.46%
Virtus ETF Advisers LLC 83,925$277,7920.15%
View complete list of ADMA BIOLOGICS INC shareholders